Dissection of the cord blood stromal component reveals predictive parameters for culture outcome

Stem Cells and Development

Volumn 24, Issue 1, 2015, Pages 104-114

  Barilani, Mario ^a,b   Lavazza, Cristiana ^a   Viganò, Mariele ^a   Montemurro, Tiziana ^a   Boldrin, Valentina ^a   Parazzi, Valentina ^a   Montelatici, Elisa ^a   Crosti, Mariacristina ^c   Moro, Monica ^c   Giordano, Rosaria ^a   Lazzari, Lorenza ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Istituto Nazionale di Genetica Molecolare   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CALCIFICATION; CELL CLONE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL SHAPE; COLONY FORMING UNIT F; CONTROLLED STUDY; CORD BLOOD DERIVED MULTIPOTENT MESENCHYMAL STROMAL CELL; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GROWTH CURVE; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STROMA CELL; MONOCYTE; MULTIPOTENT STEM CELL; OSTEOCYTE; PREDICTIVE VALUE; PRIMARY CULTURE; TELOMERE; UMBILICAL CORD BLOOD; CELL CULTURE TECHNIQUE; CYTOLOGY; FETUS BLOOD; METABOLISM;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; FETAL BLOOD; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS;

EID: 84919796854     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0160     Document Type: Article

References (49)

1. Di Trapani M, G Bassi, M Ricciardi, E Fontana, F Bifari, L Pacelli, L Giacomello, M Pozzobon, F Féron, et al. (2013). Comparative study of immune regulatory properties of stem cells derived from different tissues. Stem Cells Dev 22:2990-3002.
2. Owen M and AJ Friedenstein. (1988). Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 136:42-60.
3. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228.
4. Gronthos S, M Mankani, J Brahim, PG Robey and S Shi. (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 97:13625-13630.
5. McElreavey KD, AI Irvine, KT Ennis and WH Mc Lean. (1991). Isolation, culture and characterisation of fibroblastlike cells derived from the Wharton's jelly portion of human umbilical cord. Biochem Soc Trans 19:29S.
6. Erices A, P Conget and JJ Minguell. (2000). Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235-242.
7. Igura K, X Zhang, K Takahashi, A Mitsuru, S Yamaguchi and TA Takashi. (2004). Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 6:543-553.
8. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, DJ Prockop and Horwitz E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
9. Jin HJ, YK Bae, M Kim, SJ Kwon, HB Jeon, SJ Choi, SW Kim, YS Yang, W Oh and JW Chang. (2013). Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci 14:17986-18001.
10. Ragni E, M Viganò, V Parazzi, T Montemurro, E Montelatici, C Lavazza, S Budelli, S Vecchini, P Rebulla, R Giordano and L Lazzari. (2013). Adipogenic potential in human mesenchymal stem cells strictly depends on adult or foetal tissue harvest. Int J Biochem Cell Biol 45:2456-2466.
11. Hoogduijn MJ, MG Betjes and CC Baan. (2014). Mesenchymal stromal cells for organ transplantation: different sources and unique characteristics? Curr Opin Organ Transplant 19:41-46.
12. Goodwin HS, AR Bicknese, SN Chien, BD Bogucki, CO Quinn and DA Wall. (2001). Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 7:581-588.
13. Flynn A, F Barry and T O'Brien. (2007). UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy 9: 717-726.
14. Stubbendorff M, T Deuse, X Hua, TT Phan, K Bieback, K Atkinson, TH Eiermann, J Velden, C Schröder, et al. (2013). Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue. Stem Cells Dev 22:2619-2629.
15. Wang M, Y Yang, D Yang, F Luo, W Liang, S Guo and J Xu. (2009). The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126:220-232.
16. Riordan NH, K Chan, AM Marleau and TE Ichim. (2007). Cord blood in regenerative medicine: do we need immune suppression? J Transl Med 5:8.
17. Bieback K, S Kern, A Kocaömer, K Ferlik and P Bugert. (2008). Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood. Biomed Mater Eng 18:S71-S76.
18. Zhang X, M Hirai, S Cantero, R Ciubotariu, L Dobrila, A Hirsh, K Igura, Satoh H, Yokomi I, et al. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem 112:1206-1218.
19. Laitinen A, JNystedt and S Laitinen. (2011). The isolation and culture of human cord blood-derived mesenchymal stem cells under low oxygen conditions. Methods Mol Biol 698:63-73.
20. Sibov TT, P Severino, LC Marti, LF Pavon, DM Oliveira, PR Tobo, AH Campos, AT Paes, E Amaro, L Gamarra and CA Moreira-Filho. (2012). Mesenchymal stem cells from umbilical cord blood: parameters for isolation, characterization and adipogenic differentiation. Cytotechnology 64:511-521.
21. Bieback K, S Kern, H Klüter and H Eichler. (2004). Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22(4):625-634.
22. Crisan M, S Yap, L Casteilla, CW Chen, M Corselli, TS Park, G Andriolo, B Sun, B Zheng, et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301-313.
23. Sun HP, X Zhang, XH Chen, C Zhang, L Gao, YM Feng, XG Peng and L Gao. (2012). Human umbilical cord blood-derived stromal cells are superior to human umbilical cord bloodderived mesenchymal stem cells in inducing myeloid lineage differentiation in vitro. Stem Cells Dev 21:1429-1440.
24. Markov V, K Kusumi, MG Tadesse, DA William, DM Hall, V Lounev, A Carlton, J Leonard, RI Cohen, EF Rappaport and B Saitta. (2007). Identification of cord blood-derived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles. Stem Cells Dev 16:53-73.
25. Chang YJ, CP Tseng, LF Hsu, TB Hsieh and SM Hwang. (2006). Characterization of two populations of mesenchymal progenitor cells in umbilical cord blood. Cell Biol Int 30:495-499.
26. Kögler G, S Sensken, JA Airey, T Trapp, M Müschen, N Feldhahn, S Liedtke, RV Sorg, J Fischer, et al. (2004). A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200:123-135.
27. Ragni E, T Montemurro, E Montelatici, C Lavazza, M Viganò, P Rebulla, R Giordano and L Lazzari. (2013). Differential microRNA signature of human mesenchymal stem cells from different sources reveals an ''environmentalniche memory'' for bone marrow stem cells. Exp Cell Res 319:1562-1574.
28. Samsonraj RM, M Raghunath, JH Hui, L Ling, V Nurcombe and SM Cool. (2013). Telomere length analysis of human mesenchymal stem cells by quantitative PCR. Gene 519:348-355.
29. Ragni E, M Viganò, P Rebulla, R Giordano and L Lazzari. (2013) What is beyond a qRT-PCR study on mesenchymal stem cell differentiation properties: how to choose the most reliable housekeeping genes. J Cell Mol Med 17:168-180.
30. Laitinen A and J Laine. (2007). Isolation of mesenchymal stem cells from human cord blood. Curr Protoc Stem Cell Biol 2: 2A.3
31. Phinney DG. (2012). Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J Cell Biochem 113:2806-2812.
32. Ho AD, W Wagner and W Franke. (2008). Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 10: 320-330.
33. Siegel G, T Kluba, U Hermanutz-Klein, K Bieback, H Northoff and R Schäfer. (2013). Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med 11:146.
34. Bajek A, M Czerwinski, J Olkowska, N Gurtowska, T Kloskowski and T Drewa. (2012). Does aging of mesenchymal stem cells limit their potential application in clinical practice? Aging Clin Exp Res 24:404-411.
35. Mikhelson VM and IA Gamaley. (2012). Telomere shortening is a sole mechanism of aging in mammals. Curr Aging Sci 5:203-208.
36. Kluth SM, A Buchheiser, AP Houben, S Geyh, T Krenz, TF Radke, C Wiek, H Hanenberg, P Reinecke, P Wernet and G Kögler. (2010). DLK-1 as a marker to distinguish unrestricted somatic stem cells and mesenchymal stromal cells in cord blood. Stem Cells Dev 19:1471-1483.
37. Udagawa N, N Takahashi, T Akatsu, H Tanaka, T Sasaki, T Nishihara, T Koga, TJ Martin and T Suda. (1990). Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A 87:7260-7264.
38. KimYG,CKLee, JSOh, SHKim,KAKimandBYoo. (2010). Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes. Arthritis Rheum 62:515-523.
39. Zhong X and FJ Rescorla. (2012). Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell Signal 24:393-401.
40. Stupack DG and DA Cheresh. (2002). Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 115:3729-3738.
41. Mathieu PS and EG Loboa. (2012). Cytoskeletal and focal adhesion influences on mesenchymal stem cell shape, mechanical properties, and differentiation down osteogenic, adipogenic, and chondrogenic pathways. Tissue Eng Part B Rev 18:436-444.
42. Murray IR, CC West, WR Hardy, AW James, TS Park, A Nguyen, T Tawonsawatruk, L Lazzari, C Soo and B Peáult. (2014). Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci 71:1353-1374.
43. Wagner W, S Bork, P Horn, D Krunic, T Walenda, A Diehlmann, V Benes, J Blake, FX Huber, et al. (2009). Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 4:e5846.
44. Behrens A, van JM Deursen, KL Rudolph and B Schumacher. (2014). Impact of genomic damage and ageing on stem cell function. Nat Cell Biol 16:201-207.
45. López-Ot?n C, MA Blasco, L Partridge, M Serrano and G Kroemer. (2013). The hallmarks of aging. Cell 153:1194-1217.
46. Wagner W, AD Ho and M Zenke. (2010). Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 16:445-453.
47. Pierro M, L Ionescu, T Montemurro, A Vadivel, G Weissmann, G Oudit, D Emery, S Bodiga, F Eaton, et al. (2013). Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 68:475-484.
48. Zanier ER,MMontinaro,MViganò, P Villa, S Fumagalli, F Pischiutta, L Longhi, ML Leoni, P Rebulla, et al. (2011). Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma. Crit Care Med 39:2501-2510.
49. MorigiM, C Rota, TMontemurro, EMontelatici, Lo V Cicero, B Imberti, M Abbate, C Zoja, P Cassis, et al. (2010). Lifesparing effect of human cord blood-mesenchymal stemcells in experimental acute kidney injury. Stem Cells 28:513-522